View in EDS HTML Full Text PDF Full Text

Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing.

Saved in:
Bibliographic Details
Title: Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing.
Authors: Mastorino, Luca1 (AUTHOR) lucamastorino02@gmail.com, Dapavo, Paolo1 (AUTHOR), Ortoncelli, Michela1 (AUTHOR), Bongiovanni, Eleonora1 (AUTHOR), Liao, Yingying1 (AUTHOR), Leo, Francesco1 (AUTHOR), Quaglino, Pietro1 (AUTHOR), Ribero, Simone1 (AUTHOR)
Source: Experimental Dermatology. Feb2025, Vol. 34 Issue 2, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09066705
DOI:10.1111/exd.70062